Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
RhoVac AB ("RHOVAC") announces today, 15[th] December, that co-founder and board member Anders Ljungqvist has sold 112 700 shares in RhoVac AB. This transaction corresponds to approximately 7.8% of his total shareholding. The proceeds from the sales will exclusively be used to pay Danish capital gains tax on Mr. Ljungqvist' s shares in RHOVAC. Mr. Ljungqvist remains a member of the board of directors, with a long-term interest in the company. Mr. Ljungqvist retains 1 327 525 shares after the sale.
RhoVac CEO, Anders Månsson, comments: "As a founder, Mr. Anders Ljungqvist has obviously experienced a substantial growth in the value of his RhoVac shareholding. It is for this increase in value that he must now pay taxes in Denmark, even though there is no realisation of the value. To be able to do so Mr. Ljungqvist has had to sell off a fraction of his shares in a brokered transaction. Mr. Ljunqvist informs me that he now aims to keep the rest of his shares until the company reaches the desired transaction on RV001."